Zyxi stock forecast.

Zynex Inc (ZYXI) Company Description. Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical ... Dec 1, 2023 · View Zynex Inc ZYXI investment & stock information. Get the latest Zynex Inc ZYXI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ZYXI Zynex, Inc. Stock Price & Overview 5.23K followers $9.37 -0.17 ( -1.78%) 4:00 PM 11/27/23 NASDAQ | $USD | Post-Market: $9.50 +0.13 (+1.39%) 7:45 PM Summary …Oct 26, 2023 · Price Prediction forecast forZynex to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts ZYXI for 2023 with target levels, support & resistance insights to make informed investment decisions.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

Zynex Announces Additional Share Buyback Program ENGLEWOOD, Colo., Nov. 1, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of …

Q2 Revenue. 22 %. Increase in Revenue YOY. $ 3.4 M. Net Income. ~ 80 %. Gross Margins. Zynex Medical specializes in the manfacturing and distribution of pain management devices worldwide. Find additional investor information here.Detailed statistics for Zynex, Inc. (ZYXI) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average price ...Historical and forecast chart of Zynex stock. The chart below shows the historical price of Zynex stock and a prediction chart for the next month. For …Find the latest Bakkt Holdings, Inc. (BKKT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

lucky-photographer. Silk Road Medical ( NASDAQ: SILK) fell ~7% on Monday after Wolfe Research downgraded the medical device company to Underperform from Peer Perform, citing a revised view on its ...

3 brokerages have issued 12-month price objectives for MannKind's shares. Their MNKD share price targets range from $7.50 to $7.50. On average, they anticipate the company's stock price to reach $7.50 in the next twelve months. This suggests a possible upside of 111.9% from the stock's current price. View analysts price targets for MNKD or view ...

Stock Price Forecast The 6 analysts offering 12-month price forecasts for Torm PLC have a median target of 38.11, with a high estimate of 39.35 and a low estimate of 37.92.Feb 26, 2021 · Shares of Zynex (ZYXI 5.07%) ... An even bigger issue, though, was that Zynex's 2021 Q1 forecast fell short of analysts' views. The company projects Q1 revenue between $23 million and $24.5 ... The latest Zynex stock prices, stock quotes, news, and ZYXI history to help you invest and trade smarter. ... The 9 analysts offering price forecasts for Zynex have a median target of 18.89, with ...Jan 17, 2023 · Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ... We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...

Zynex will have the flexibility to repurchase stock through a combination of open market and negotiated transactions, effectively commencing on November 1, 2023, and concluding on November 1, 2024, or when the aforementioned financial limit is attained. ... ZYXI Strong Buy Updated on: 04/12/2023. Financial Health. Very Healthy . Debt to equity ...Zynex Named as a Winner in the Deloitte 2022 Technology Fast 500TM Awards for the 4th Consecutive Year. (PR Newswire) Nov-04-22 06:59AM. Zynex, Inc. (NASDAQ:ZYXI) Shares Could Be 47% Below Their Intrinsic Value Estimate. (Simply Wall St.) +5.71%.Zynex will have the flexibility to repurchase stock through a combination of open market and negotiated transactions, effectively commencing on November 1, 2023, and concluding on November 1, 2024, or when the aforementioned financial limit is attained. ... ZYXI Strong Buy Updated on: 04/12/2023. Financial Health. Very Healthy . Debt to equity ...52-Week Range $7.45 - $17.25. Previous Close $7.71. Volume 37.72K. Average Volume (3M) 265.70K. Market Cap. $274.83M. Enterprise Value N/A. Total Cash (Recent Filing) $58.75M. Total Debt (Recent Filing) $71.35M.Stock Price Forecast The 6 analysts offering 12-month price forecasts for Torm PLC have a median target of 38.11, with a high estimate of 39.35 and a low estimate of 37.92. Oct 27, 2023 · Unraveling Zynex (ZYXI) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Zynex and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Zix Co. (NASDAQ:ZIXI) posted its quarterly earnings data on Sunday, November, 7th. The software maker reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. The software maker had revenue of $64.90 million for the quarter, compared to the consensus estimate of $64.18 million.

Fintel reports that on April 28, 2023, HC Wainwright & Co. reiterated coverage of Zynex (NASDAQ:ZYXI) with a Buy recommendation. Analyst Price Forecast Suggests 96.15% Upside. As of April 24, 2023 ...Zynex stock price predictions for 2021, 2022, 2023, 2024, 2025 using artificial intelligence. How much will Zynex cost in 2021 – 2025?

On November 3, 2023, NVRO’s stock price decreased by -$0.06, resulting in a percentage change of -0.15%. Other stocks in the industry, such as IRMD and ZYXI, had slight changes in their stock prices. NVRO’s next reporting date is scheduled for February 21, 2024, with analysts forecasting an EPS of -$0.30 for the current quarter.Oct 24, 2023 · Zynex tomorrow. We’ve gathered insights from a variety of expert analysts and amalgamated them to present an integrated daily outlook for Zynex shares for the forthcoming month. The nature of short-term forecasts often leads to a decrease in precision, attributed to the myriad of elements at play in the volatile financial markets. The Zynex stock forecast for tomorrow is $ 9.26, which would represent a 0.43% gain compared to the current price. In the next week, the price of ZYXI is expected to increase by 10.89% and hit $ 10.22. As far as the long-term Zynex stock forecast is concerned, here’s what our predictions are ... Price Prediction Zynex price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.What is the current Price Target and Forecast for Zynex (ZYXI) Zynex (ZYXI) (Delayed Data from NSDQ) $9.54 USD +0.46 (5.07%) Updated Nov 24, 2023 12:59 PM ET After-Market: $9.57 +0.03 (0.31%)...ZYXI | Complete Zynex Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.Oct 26, 2023 · Price Prediction forecast forZynex to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts ZYXI for 2023 with target levels, support & resistance insights to make informed investment decisions.

Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Zynex Inc have a median target of 18.25, with a high estimate of 27.00 and a low estimate of 13.00. The median estimate ...

Find the latest news headlines from Zynex, Inc. Common Stock (ZYXI) at Nasdaq.com.

Find the latest SEC Filings data for Zynex, Inc. Common Stock (ZYXI) at Nasdaq.com.Apr 20, 2023 · Still, analysts peg ZYXI as a consensus moderate buy. Their average price target comes out to $24, implying over 100% upside potential. Their average price target comes out to $24, implying over ... What happened. Shares of Zynex ( ZYXI 5.07%) were crashing 17.8% lower as of 11:21 a.m. EST on Friday. The steep drop came after the medical technology company announced its fourth-quarter …Nov 30, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Zynex stock is Buy based on the current 4 buy ratings for ZYXI. The average twelve-month price prediction for Zynex is $19.75 with a high price target of $28.00 and a low price target of $13.00. Learn more on ZYXI's analyst rating history. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.Oct 12, 2020 · Shares of Zynex ( ZYXI -0.62%) were tanking 26.5% lower as of 11:20 a.m. EDT on Monday. The big decline came after the medical technology company announced lower-than-expected orders for the third ... Also, the expert forecasts a $3.50 price target, implying nearly 592% upside potential. Thus, it could be one of the high growth stocks to buy for extreme speculators.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Stock Price Forecast The 6 analysts offering 12-month price forecasts for Torm PLC have a median target of 38.11, with a high estimate of 39.35 and a low estimate of 37.92.Given the current short-term trend, the stock is expected to rise 27.27% during the next 3 months and, with a 90% probability hold a price between $18.62 and $27.92 The stock …

Oct 27, 2023 · Unraveling Zynex (ZYXI) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Zynex and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Zynex Inc. Stock Price: Bottom Line. As of May 1, 2023, Zynex Inc.’s stock price is $13.34, which is up 16.61% from its previous closing price. At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios ...Zynex management will host the conference call, followed by a question and answer session.. Date: Thursday, October 26, 2023 Time: 4:15 PM Eastern Time (1:15 PM Pacific Time) U.S. dial-in number ...Instagram:https://instagram. which app is best for cryptocurrencymaft earningsnovagold stockon semiconductor corporation stock The Zynex stock forecast for tomorrow is $ 9.26, which would represent a 0.43% gain compared to the current price. In the next week, the price of ZYXI is expected to increase by 10.89% and hit $ 10.22. As far as the long-term Zynex stock forecast is concerned, here’s what our predictions are ...U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Paycom Software, Inc. PAYC shares dipped 37.1% to $154 ... commercial property crowdfundingus refineries allforecast.com tsly price Jul 2, 2023 · Zynex stock price predictions for 2023 using artificial intelligence. How much will Zynex stock be worth in 2023? ... Zynex (ZYXI) stock consensus forecasts for 2023 ... Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation.